ConductScience.org, home

Paper346283

Clinical pharmacokinetics of methotrexate.

Shen DD and 1 other. Clin Pharmacokinet, 1978. Cited by 217 papers, by iCite.

Cite this record

ConductScience Library. Clinical pharmacokinetics of methotrexate. Papers, record 346283. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/346283

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacokinetics of methotrexate.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
217
iCite
Relative citation ratio, by iCite
8.75
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shen DDD D
2Azarnoff DLD L

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethotrexateMajor topic
Administration, Oral
Bile
Blood Proteins
Cell Membrane
Central Nervous System
Drug Administration Schedule
Drug Combinations
Erythrocytes
Humans
Injections, Intramuscular
Kidney
Kinetics
Neoplasms
Protein Binding
Psoriasis

Source PubMed

Download CSV of topics

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
152104Letter: Purity of methotrexate.Lancet1975https://conductscience.org/library/papers/52104PubMed
21182692Tissue-specific synthesis of methotrexate polyglutamates in the rat.Cancer Res1975https://conductscience.org/library/papers/1182692PubMed
34197190Polygammaglutamyl metabolites of methotrexate.Biochem Biophys Res Commun1973https://conductscience.org/library/papers/4197190PubMed
45349626The effect of organic acids on renal clearance of methotrexate in man.Clin Pharmacol Ther1969https://conductscience.org/library/papers/5349626PubMed
5832268The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion.Cancer Res1977https://conductscience.org/library/papers/832268PubMed
64284746The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man.Cancer Res1965https://conductscience.org/library/papers/4284746PubMed
75289428The characteristics of the membrane transport of amethopterin and the naturally occurring folates.Ann N Y Acad Sci1971https://conductscience.org/library/papers/5289428PubMed
814149915METHOTREXATE DISPLACEMENT IN MAN.J Clin Invest1964https://conductscience.org/library/papers/14149915PubMed
91131258Stoichiometric inhibition of mammalian dihydrofolate reductase by the gamma-glutamyl metabolite of methotrexiate, 4-amino-4-deoxy-N-10-methylpteroylglutamyl-gamma-glutamate.Biochem Biophys Res Commun1975https://conductscience.org/library/papers/1131258PubMed
104723265Pharmacokinetics of methotrexate.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4723265PubMed
115289427Metabolism of folate antagonists.Ann N Y Acad Sci1971https://conductscience.org/library/papers/5289427PubMed
125345205Antibiotics alter methotrexate metabolism and excretion.Science1969https://conductscience.org/library/papers/5345205PubMed
131109785Inhibition of renal tubular transport of methotrexate by probenecid.Cancer Res1975https://conductscience.org/library/papers/1109785PubMed
144429965Effect of route of administration and effusions on methotrexate pharmacokinetics.Cancer Res1974https://conductscience.org/library/papers/4429965PubMed
164517004Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.N Engl J Med1973https://conductscience.org/library/papers/4517004PubMed
1710623837-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.J Clin Invest1976https://conductscience.org/library/papers/1062383PubMed
18806016Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.N Engl J Med1975https://conductscience.org/library/papers/806016PubMed
191175171Kinetic model for the disposition and metabolism of moderate and high-dose methotrexate (NSC-740) in man.Cancer Chemother Rep1975https://conductscience.org/library/papers/1175171PubMed
201273152The synergistic effect of salicylates on methotrexate toxicity.Plast Reconstr Surg1976https://conductscience.org/library/papers/1273152PubMed
215042796Secretion of methotrexate into human milk.Am J Obstet Gynecol1972https://conductscience.org/library/papers/5042796PubMed

See all 56 referencesDownload CSV of references

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 217 citations.

PMIDTitleJournalYearIn PapersSource
41954735Half-dose glucarpidase: an effective rescue for toxic methotrexate plasma concentrations in a patient with bilateral primary vitreoretinal lymphoma.Ann Hematol2026https://conductscience.org/library/papers/41954735PubMed
41950802Emerging mechanistic trends and clinical efficacy for methotrexate: Applications to inflammatory bowel disease.Pharmacol Rev2026https://conductscience.org/library/papers/41950802PubMed
40601470Prescribing Inflammatory Bowel Disease Medications in Chronic Kidney Disease: A Practical Guide.Aliment Pharmacol Ther2025https://conductscience.org/library/papers/40601470PubMed
39403008Is the GFR-based scaling approach adequate for predicting pediatric renal clearance of drugs with passive tubular reabsorption? Insights from PBPK modeling.CPT Pharmacometrics Syst Pharmacol2025https://conductscience.org/library/papers/39403008PubMed
38303016Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use.BMC Pharmacol Toxicol2024https://conductscience.org/library/papers/38303016PubMed
37934204Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review.Eur J Clin Pharmacol2024https://conductscience.org/library/papers/37934204PubMed
37446715Rhodiola rosea L. Extract, a Known Adaptogen, Evaluated in Experimental Arthritis.Molecules2023https://conductscience.org/library/papers/37446715PubMed
35236714Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.Clin J Am Soc Nephrol2022https://conductscience.org/library/papers/35236714PubMed
34669022Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.Cancer Chemother Pharmacol2022https://conductscience.org/library/papers/34669022PubMed
34200242Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies.Cancers (Basel)2021https://conductscience.org/library/papers/34200242PubMed
33177476Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.J Acquir Immune Defic Syndr2020https://conductscience.org/library/papers/33177476PubMed
32982497Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients.Open Access Rheumatol2020https://conductscience.org/library/papers/32982497PubMed
32699674High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance.Cureus2020https://conductscience.org/library/papers/32699674PubMed
31890337Analytical methodologies for determination of methotrexate and its metabolites in pharmaceutical, biological and environmental samples.J Pharm Anal2019https://conductscience.org/library/papers/31890337PubMed
29512050Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.Clin Pharmacokinet2018https://conductscience.org/library/papers/29512050PubMed
28148280Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.Trials2017https://conductscience.org/library/papers/28148280PubMed
26457382Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.Inflamm Bowel Dis2016https://conductscience.org/library/papers/26457382PubMed
25004821Predicting when biliary excretion of parent drug is a major route of elimination in humans.AAPS J2014https://conductscience.org/library/papers/25004821PubMed
24433481Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.Br J Clin Pharmacol2014https://conductscience.org/library/papers/24433481PubMed
22950522Pharmacokinetics, safety, and tolerability of GLPG0259, a mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5) inhibitor, given as single and multiple doses to healthy male subjects.Drugs R D2012https://conductscience.org/library/papers/22950522PubMed

See all 57 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/346283

GET https://conductscience.org/api/papers/v1/346283/references?page=2